|
Thrombosis risk factors
Citations 121-130 of 164 total displayed.
|
Past content
(since Dec 2000):
|
- Clinical Investigations and Reports
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women
- Paul M Ridker, Julie E. Buring, Nancy R. Cook, and Nader Rifai
Circulation 2003;107:391-397; published online before print as doi:10.1161/01.CIR.0000055014.62083.05
[Abstract]
[Full text]
- Clinical Investigations and Reports
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women
- Paul M Ridker, Julie E. Buring, Nancy R. Cook, and Nader Rifai
Circulation published January 27, 2003, doi:10.1161/01.CIR.0000055014.62083.05
[Abstract]
[Full text]
- Articles
Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes
- James A. de Lemos, David A. Morrow, Marc S. Sabatine, Sabina A. Murphy, C. Michael Gibson, Elliott M. Antman, Carolyn H. McCabe, Christopher P. Cannon, and Eugene Braunwald
Circulation published January 20, 2003, doi:10.1161/01.CIR.0000049742.68848.99
[Abstract]
- Brief Rapid Communications
Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism
- Anetta Undas, Wojciech J. Sydor, Kathleen Brummel, Jacek Musial, Kenneth G. Mann, and Andrew Szczeklik
Circulation 2003;107:17-20; published online before print as doi:10.1161/01.CIR.0000047062.03282.A3
[Abstract]
[Full text]
- Clinical Investigations and Reports
Oxidized Low-Density Lipoprotein Augments and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Limit CD40 and CD40L Expression in Human Vascular Cells
- Uwe Schönbeck, Norbert Gerdes, Nerea Varo, Rebecca S. Reynolds, Daniel B. Horton, Udo Bavendiek, Linda Robbie, Peter Ganz, Scott Kinlay, and Peter Libby
Circulation 2002;106:2888-2893; published online before print as doi:10.1161/01.CIR.0000043029.52803.7B
[Abstract]
[Full text]
- Articles
Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism
- Anetta Undas, Wojciech J. Sydor, Kathleen Brummel, Jacek Musial, Kenneth G. Mann, and Andrew Szczeklik
Circulation published December 2, 2002, doi:10.1161/01.CIR.0000047062.03282.A3
[Abstract]
- Correspondence
Reasons for Resistance to Aspirin in Cardiovascular Disease • Response
- A. Szczeklik, J. Musia
 , A. Undas, John W. Eikelboom, Jack Hirsh, Jeffrey I. Weitz, Marilyn Johnston, Qilong Yi, and Salim Yusuf
Circulation 2002;106:e181-182e, doi:10.1161/01.CIR.0000037294.28723.DA
[Full text]
- Articles
Oxidized Low-Density Lipoprotein Augments and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Limit CD40 and CD40L Expression in Human Vascular Cells
- Uwe Schönbeck, Norbert Gerdes, Nerea Varo, Rebecca S. Reynolds, Daniel B. Horton, Udo Bavendiek, Linda Robbie, Peter Ganz, Scott Kinlay, and Peter Libby
Circulation published November 18, 2002, doi:10.1161/01.CIR.0000043029.52803.7B
[Abstract]
- Clinical Investigations and Reports
Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors
- Dwayne S.G. Conway, Lesly A. Pearce, Bernard S.P. Chin, Robert G. Hart, and Gregory Y.H. Lip
Circulation 2002;106:1962-1967; published online before print as doi:10.1161/01.CIR.0000033220.97592.9A
[Abstract]
[Full text]
- Current Perspectives
Upper-Extremity Deep Vein Thrombosis
- Hylton V. Joffe and Samuel Z. Goldhaber
Circulation 2002;106:1874-1880, doi:10.1161/01.CIR.0000031705.57473.1C
[Full text]
|
|
